Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment

High Antiproliferative Activity of Hydroxythiopyridones over Hydroxypyridones and Their Organoruthenium Complexes

(2021) Md. Salman Shakil et al.   Biomedicines

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Surgery for Colorectal Cancer: A Trigger for Liver Metastases Development? New Insights into the Underlying Mechanisms

(2021) Simran Grewal et al.   Biomedicines

Platinum(II) Drug-Loaded Gold Nanoshells for Chemo-Photothermal Therapy in Colorectal Cancer

(2020) Shin-Yu Lee et al.   ACS Applied Materials & Interfaces

Ru@CeO2 yolk shell nanozymes: Oxygen supply in situ enhanced dual chemotherapy combined with photothermal therapy for orthotopic/subcutaneous colorectal cancer

(2020) Xufeng Zhu et al.   BIOMATERIALS

Blood-triggered generation of platinum nanoparticle functions as an anti-cancer agent

(2020) Xin Zeng et al.   Nature Communications

Recent advances in anticancer ruthenium Schiff base complexes

(2020) Shazia Parveen   APPLIED ORGANOMETALLIC CHEMISTRY

Immunogenic cell death in colon cancer prevention and therapy

(2020) Hang Ruan et al.   MOLECULAR CARCINOGENESIS

Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events

(2020) Guoguo Jin et al.   Oxidative Medicine and Cellular Longevity

Mesoporous platinum nanoparticle-based nanoplatforms for combined chemo-photothermal breast cancer therapy

(2020) Bei Fu et al.   JOURNAL OF COLLOID AND INTERFACE SCIENCE

Antitumor Activity of Ruthenium(II) Terpyridine Complexes towards Colon Cancer Cells In Vitro and In Vivo

(2020) Maja Savic et al.   MOLECULES

5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation

(2020) Yong-Hee Cho et al.   Nature Communications

Roles of IFN-γ in tumor progression and regression: a review

(2020) Dragica Jorgovanovic et al.   Biomarker Research

Potent half-sandwich Ru(Ⅱ) N^N (aryl-BIAN) complexes: Lysosome-mediated apoptosis, in vitro and in vivo anticancer activities

(2020) Zhishan Xu et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements

(2020) Ahmed Malki et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives

(2020) Sang Yeul Lee et al.   Drug Design Development and Therapy

Luminescent Ruthenium(II) Polypyridine Complexes for a Wide Variety of Biomolecular and Cellular Applications

(2019) Justin Shum et al.   INORGANIC CHEMISTRY

The role of thioredoxin system in cancer: strategy for cancer therapy

(2019) Jin-Jing Jia et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities

(2019) Suhas Vasaikar et al.   CELL

Discovery of Cisplatin Binding to Thymine and Cytosine on a Single-Stranded Oligodeoxynucleotide by High Resolution FT-ICR Mass Spectrometry

(2019) Wenjuan Zeng et al.   MOLECULES

Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials

(2019) Gerardo Rosati et al.   Cancers

Ru(II)-thymine complex causes DNA damage and apoptotic cell death in human colon carcinoma HCT116 cells mediated by JNK/p38/ERK1/2 via a p53-independent signaling

(2019) Suellen L. R. Silva et al.   Scientific Reports

Ruthenium Complexes With Piplartine Cause Apoptosis Through MAPK Signaling by a p53-Dependent Pathway in Human Colon Carcinoma Cells and Inhibit Tumor Development in a Xenograft Model

(2019) Ingrid R. S. Baliza et al.   Frontiers in Oncology

Nanovectors Design for Theranostic Applications in Colorectal Cancer

(2019) Riccardo Rampado et al.   Journal of Oncology

Colorectal cancer

(2019) Evelien Dekker et al.   LANCET

Integrated Combination Treatment Using a “Smart” Chemotherapy and MicroRNA Delivery System Improves Outcomes in an Orthotopic Colorectal Cancer Model

(2018) Hai-Jun Liu et al.   ADVANCED FUNCTIONAL MATERIALS

Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer

(2018) Rona Yaeger et al.   CANCER CELL

The side effects of platinum-based chemotherapy drugs: a review for chemists

(2018) Rabbab Oun et al.   DALTON TRANSACTIONS

Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis

(2018) Hsi-Hsien Hsu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Cytotoxic activity and structural features of Ru(II)/phosphine/amino acid complexes

(2018) Edjane R. dos Santos et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Deciphering the biochemical and molecular mechanism underlying the in vitro and in vivo chemotherapeutic efficacy of ruthenium quercetin complex in colon cancer

(2018) Souvik Roy et al.   MOLECULAR CARCINOGENESIS

A ruthenium-based 5-fluorouracil complex with enhanced cytotoxicity and apoptosis induction action in HCT116 cells

(2018) Valdenizia Rodrigues Silva et al.   Scientific Reports

Platinum Nanoworms for Imaging-guided Combined Cancer Therapy in the Second Near-Infrared Window

(2018) Qingxi Ma et al.   Journal of Materials Chemistry B

Acute toxic effects of ruthenium (II)/amino acid/diphosphine complexes on Swiss mice and zebrafish embryos

(2018) Francyelli Mello-Andrade et al.   BIOMEDICINE & PHARMACOTHERAPY

Lysosome-Targeted Chemotherapeutics: Half-Sandwich Ruthenium(II) Complexes That Are Selectively Toxic to Cancer Cells

(2018) Zhenzhen Tian et al.   INORGANIC CHEMISTRY

Binding of Organometallic Ruthenium Anticancer Complexes to DNA: Thermodynamic Base and Sequence Selectivity

(2018) Suyan Liu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

PARP INHIBITION IN PLATINUM-BASED CHEMOTHERAPY: CHEMOPOTENTIATION AND NEUROPROTECTION

(2018) Rachel M McQuade et al.   PHARMACOLOGICAL RESEARCH

A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53

(2018) Vania Vidimar et al.   CANCER LETTERS

Oxaliplatin-Induced Neurotoxic Side Effects and Their Impact on Daily Activities

(2018) Jenny Drott et al.   CANCER NURSING

Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433

(2018) Susan Monro et al.   CHEMICAL REVIEWS

The reduction of ruthenium(III) complexes with triazolopyrimidine ligands by ascorbic acid and mechanistic insight into their action in anticancer therapy

(2018) Joanna Wiśniewska et al.   INORGANICA CHIMICA ACTA

A Ruthenium(II) N-Heterocyclic Carbene (NHC) Complex with Naphthalimide Ligand Triggers Apoptosis in Colorectal Cancer Cells via Activating the ROS-p38 MAPK Pathway

(2018) Yasamin Dabiri et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Binding of platinum derivative, oxaliplatin to deoxyribonucleic acid: structural insight into antitumor action

(2018) Bhumika Ray et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Correlation of ERK/MAPK signaling pathway with proliferation and apoptosis of colon cancer cells

(2018) Gang Zhou et al.   Oncology Letters

Applications of Ruthenium Complex in Tumor Diagnosis and Therapy

(2018) Ke Lin et al.   Frontiers in Pharmacology

Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors

(2017) Prakash Thangavel et al.   International Journal of Nanomedicine

Influence of components of tumour microenvironment on the response of HCT-116 colorectal cancer to the ruthenium-based drug NAMI-A

(2017) Alberta Bergamo et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Advances in the design of organometallic anticancer complexes

(2017) Pingyu Zhang et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

Lysosomes as Oxidative Targets for Cancer Therapy

(2017) Rebecca F. Dielschneider et al.   Oxidative Medicine and Cellular Longevity

Metal complexes in cancer therapy – an update from drug design perspective

(2017) Umar Ndagi et al.   Drug Design Development and Therapy

Role of glucose metabolism related gene GLUT1 in the occurrence and prognosis of colorectal cancer

(2017) Wenming Feng et al.   Oncotarget

Identification of pharmacological agents that induce HMGB1 release

(2017) Peng Liu et al.   Scientific Reports

Calreticulin Release at an Early Stage of Death Modulates the Clearance by Macrophages of Apoptotic Cells

(2017) Rim Osman et al.   Frontiers in Immunology

Development and progression of colorectal neoplasia

(2017) Upender Manne et al.   Cancer Biomarkers

The Challenges of Colorectal Cancer Survivorship

(2017) Crystal S. Denlinger et al.   Journal of the National Comprehensive Cancer Network

Nanotechnologies in Cancer Treatment and Diagnosis

(2017) Stephanie A. Morris et al.   Journal of the National Comprehensive Cancer Network

Electronic State of Sodium trans-[Tetrachloridobis(1H-indazole)ruthenate(III)] (NKP-1339) in Tumor, Liver and Kidney Tissue of a SW480-bearing Mouse

(2017) Amir Blazevic et al.   Scientific Reports

Perfluorocarbon-Loaded Hollow Bi2Se3Nanoparticles for Timely Supply of Oxygen under Near-Infrared Light to Enhance the Radiotherapy of Cancer

(2016) Guosheng Song et al.   ADVANCED MATERIALS

p53-independent structure-activity relationships of 3-ring mesogenic compounds’ activity as cytotoxic effects against human non-small cell lung cancer lines

(2016) Saori Fukushi et al.   BMC CANCER

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Platinum-based drugs: past, present and future

(2016) Shahana Dilruba et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Versatile synthesis of cationic N-heterocyclic carbene–gold(i) complexes containing a second ancillary ligand. Design of heterobimetallic ruthenium–gold anticancer agents

(2016) Jacob Fernández-Gallardo et al.   CHEMICAL COMMUNICATIONS

Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy

(2016) Chao Liang et al.   CHEMICAL SOCIETY REVIEWS

Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective

(2016) Enzo Alessio   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Molecular mode of action of NKP-1339 – a clinically investigated ruthenium-based drug – involves ER- and ROS-related effects in colon carcinoma cell lines

(2016) Lea S. Flocke et al.   INVESTIGATIONAL NEW DRUGS

A novel dual-functioning ruthenium(II)–arene complex of an anti-microbial ciprofloxacin derivative — Anti-proliferative and anti-microbial activity

(2016) Ziga Ude et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA = 1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties

(2016) F. Battistin et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Inhibition of adhesion, migration and of α5β1 integrin in the HCT-116 colorectal cancer cells treated with the ruthenium drug NAMI-A

(2016) Chiara Pelillo et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Systematical investigation of binding interaction between novel ruthenium(II) arene complex with curcumin analogs and ctDNA

(2016) Shan Huang et al.   LUMINESCENCE

Up-Regulation of ENO1 by HIF-1α in Retinal Pigment Epithelial Cells after Hypoxic Challenge Is Not Involved in the Regulation of VEGF Secretion

(2016) Feihui Zheng et al.   PLoS One

Radiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes

(2016) R Carter et al.   Scientific Reports

Photodynamic killing of cancer cells by a Platinum(II) complex with cyclometallating ligand

(2016) Rachel E. Doherty et al.   Scientific Reports

Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma

(2016) Marios Giannakis et al.   Cell Reports

p53 in the DNA-Damage-Repair Process

(2016) Ashley B. Williams et al.   Cold Spring Harbor Perspectives in Medicine

Colorectal cancer carcinogenesis: a review of mechanisms

(2016) Kanwal Tariq et al.   Cancer Biology & Medicine

Targeting the lysosome in cancer

(2015) Shengfu Piao et al.   Annals of the New York Academy of Sciences

The state-of-play and future of platin drugs

(2015) M. Apps et al.   ENDOCRINE-RELATED CANCER

Cell death induced by endoplasmic reticulum stress

(2015) Raffaella Iurlaro et al.   FEBS Journal

Colorectal Cancer Metastases Settle in the Hepatic Microenvironment Through α5β1 Integrin

(2015) Chiara Pelillo et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Cyclopentadienyl–Ruthenium(II) and Iron(II) Organometallic Compounds with Carbohydrate Derivative Ligands as Good Colorectal Anticancer Agents

(2015) Pedro R. Florindo et al.   JOURNAL OF MEDICINAL CHEMISTRY

FBXW7 negatively regulates ENO1 expression and function in colorectal cancer

(2015) Panpan Zhan et al.   LABORATORY INVESTIGATION

Principles of nanoparticle design for overcoming biological barriers to drug delivery

(2015) Elvin Blanco et al.   NATURE BIOTECHNOLOGY

A novel class of ruthenium-based photosensitizers effectively kills in vitro cancer cells and in vivo tumors

(2015) Jamie Fong et al.   PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES

Novel recurrently mutated genes in African American colon cancers

(2015) Kishore Guda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Interaction of aquated form of ruthenium(III) anticancer complexes with normal and mismatch base pairs: A density functional theoretical study

(2015) Dharitri Das et al.   Computational and Theoretical Chemistry

HIF-1α pathway: role, regulation and intervention for cancer therapy

(2015) Georgina N. Masoud et al.   Acta Pharmaceutica Sinica B

Anticancer Potency Studies of Coordination Driven Self-Assembled Arene-Ru-Based Metalla-Bowls

(2014) Anurag Mishra et al.   CHEMBIOCHEM

Preclinical combination therapy of the investigational drug NAMI-A+ with doxorubicin for mammary cancer

(2014) Alberta Bergamo et al.   INVESTIGATIONAL NEW DRUGS

Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy

(2014) Suzanne Leijen et al.   INVESTIGATIONAL NEW DRUGS

Discovery and Investigation of Anticancer Ruthenium–Arene Schiff-Base Complexes via Water-Promoted Combinatorial Three-Component Assembly

(2014) Mun Juinn Chow et al.   JOURNAL OF MEDICINAL CHEMISTRY

Targeting Nucleus DNA with a Cyclometalated Dipyridophenazineruthenium(II) Complex

(2014) Huaiyi Huang et al.   JOURNAL OF MEDICINAL CHEMISTRY

NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

(2014) Robert Trondl et al.   Chemical Science

The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models

(2014) D J Colin et al.   Cell Death & Disease

The Role of Hypoxia-Inducible Factor-1α, Glucose Transporter-1, (GLUT-1) and Carbon Anhydrase IX in Endometrial Cancer Patients

(2014) Pawel Sadlecki et al.   Biomed Research International

Oxaliplatin-induced immune-mediated cytopenias: A case report and literature review

(2014) Nicholas P Forcello et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Oxaliplatin induces different cellular and molecular chemoresistance patterns in colorectal cancer cell lines of identical origins

(2013) Piroska Virag et al.   BMC GENOMICS

Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells

(2013) Hana Janouskova et al.   CANCER LETTERS

Organometallic anticancer complexes of lapachol: metal centre-dependent formation of reactive oxygen species and correlation with cytotoxicity

(2013) Wolfgang Kandioller et al.   CHEMICAL COMMUNICATIONS

Inducers of immunogenic cancer cell death

(2013) Aleksandra M. Dudek et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Crosstalk between ER stress and immunogenic cell death

(2013) Oliver Kepp et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Ruthenium complexes in different oxidation states: synthesis, crystal structure, spectra and redox properties

(2013) Agnieszka Jabłońska-Wawrzycka et al.   DALTON TRANSACTIONS

Long term effect of surgery and radiotherapy for colorectal cancer on defecatory function and quality of life

(2013) Gillian Knowles et al.   European Journal of Oncology Nursing

Synthesis, Characterization, and Anticancer Activity of a Series of Ketone-N4-Substituted Thiosemicarbazones and Their Ruthenium(II) Arene Complexes

(2013) Wei Su et al.   INORGANIC CHEMISTRY

Nanoformulation Improves Activity of the (pre)Clinical Anticancer Ruthenium Complex KP1019

(2013) P. Heffeter et al.   Journal of Biomedical Nanotechnology

The role of FAK in tumor metabolism and therapy

(2013) Jianliang Zhang et al.   PHARMACOLOGY & THERAPEUTICS

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

(2013) J. Gao et al.   Science Signaling

Arene-RuIIComplexes of Curcumin Exert Antitumor Activity via Proteasome Inhibition and Apoptosis Induction

(2012) Laura Bonfili et al.   ChemMedChem

Recurrent R-spondin fusions in colon cancer

(2012) Somasekar Seshagiri et al.   NATURE

Comprehensive molecular characterization of human colon and rectal cancer

(2012)   NATURE

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

Platinum nanoparticles and their cellular uptake and DNA platination at non-cytotoxic concentrations

(2011) Helge Gehrke et al.   ARCHIVES OF TOXICOLOGY

XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results

(2011) J Cassidy et al.   BRITISH JOURNAL OF CANCER

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Photodynamic therapy of cancer: An update

(2011) Patrizia Agostinis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Transition Metal Based Anticancer Drugs

(2011) K. Benjamin Garbutcheon-Singh et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Half-sandwich ruthenium–arene complexes with thiosemicarbazones: Synthesis and biological evaluation of [(η6-p-cymene)Ru(piperonal thiosemicarbazones)Cl]Cl complexes

(2011) Floyd Beckford et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Synthesis and characterization of mixed-ligand diimine-piperonal thiosemicarbazone complexes of ruthenium(II): Biophysical investigations and biological evaluation as anticancer and antibacterial agents

(2011) Floyd A. Beckford et al.   JOURNAL OF MOLECULAR STRUCTURE

Butyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells

(2010) Yu Zhang et al.   CHEMICO-BIOLOGICAL INTERACTIONS

[Ru(bpy)3−n(dpb)n]2+: Unusual Photophysical Property and Efficient DNA Photocleavage Activity

(2010) Qian-Xiong Zhou et al.   INORGANIC CHEMISTRY

Impact of the Carbon Chain Length of Novel Palladium(II) Complexes on Interaction with DNA and Cytotoxic Activity

(2010) Enjun Gao et al.   INORGANIC CHEMISTRY

Oxaliplatin-Mediated Increase in Spleen Size As a Biomarker for the Development of Hepatic Sinusoidal Injury

(2010) Michael J. Overman et al.   JOURNAL OF CLINICAL ONCOLOGY

Platinum nanoparticles: a promising material for future cancer therapy?

(2010) Erika Porcel et al.   NANOTECHNOLOGY

Penetrative DNA intercalation and G-base selectivity of an organometallic tetrahydroanthracene RuII anticancer complex

(2010) Hong-Ke Liu et al.   Chemical Science

Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study

(2009) Frederike Lentz et al.   ANTI-CANCER DRUGS

Synthesis, molecular structure and evaluation of new organometallic ruthenium anticancer agents

(2009) Kenneth D. Camm et al.   DALTON TRANSACTIONS

Areneruthenium complexes as anticancer agents

(2009) Georg Süss-Fink   DALTON TRANSACTIONS

Isolated Seven-Coordinate Ru(IV) Dimer Complex with [HOHOH]−Bridging Ligand as an Intermediate for Catalytic Water Oxidation

(2009) Lele Duan et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Dose Escalation Methods in Phase I Cancer Clinical Trials

(2009) Christophe Le Tourneau et al.   JNCI-Journal of the National Cancer Institute

Recent developments in ruthenium anticancer drugs

(2009) Aviva Levina et al.   Metallomics

Targeting both HIF-1 and HIF-2 in human colon cancer cells improves tumor response to sunitinib treatment

(2009) K. Burkitt et al.   MOLECULAR CANCER THERAPEUTICS

Tumor Suppressive Functions of p53

(2009) J. T. Zilfou et al.   Cold Spring Harbor Perspectives in Biology

Lysosomal involvement in cell death and cancer

(2008) Thomas Kirkegaard et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Curcumin Inhibits the Proteasome Activity in Human Colon Cancer Cells In vitro and In vivo

(2008) V. Milacic et al.   CANCER RESEARCH

Autophagy in the Pathogenesis of Disease

(2008) Beth Levine et al.   CELL

KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients

(2008) Christian G. Hartinger et al.   CHEMISTRY & BIODIVERSITY

HIF-1α and HIF-2α have divergent roles in colon cancer

(2008) Takaaki Imamura et al.   INTERNATIONAL JOURNAL OF CANCER

Lysosomal membrane permeabilization in cell death

(2008) P Boya et al.   ONCOGENE

Catalytic organometallic anticancer complexes

(2008) S. J. Dougan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antitumour metal compounds: more than theme and variations

(2007) Michael A. Jakupec et al.   DALTON TRANSACTIONS